Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00670644
Other study ID # CDR0000587714
Secondary ID P30CA068485VU-VI
Status Completed
Phase N/A
First received May 1, 2008
Last updated April 7, 2017
Start date May 2006
Est. completion date March 2011

Study information

Verified date April 2017
Source Vanderbilt University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

RATIONALE: Identifying why patients don't do self care for lymphedema may help doctors plan better at-home self-care treatment.

PURPOSE: This research study is looking at self-care practices for lymphedema in patients with breast cancer.


Description:

OBJECTIVES:

Primary

- To systematically identify and describe the barriers to completing recommended at home self-care of lymphedema in patients with breast cancer.

- To identify patient recalled instructions as to at home self-care practices for lymphedema as told to them by healthcare professionals and others.

- To identify the current at home self-care practices of breast cancer survivors with treatment treated lymphedema.

Secondary

- To examine the relationship between at home self-care activities and symptoms in breast cancer survivors with lymphedema.

- To examine the relationship between at home self-care activities and quality of life in breast cancer survivors with lymphedema.

- To identify patient-perceived benefits to at home self-care.

OUTLINE: Patients complete questionnaires about their breast cancer diagnosis and treatment history, lymphedema history and problems, and years of education and income. Patients also complete surveys about home self-care practices for lymphedema and any benefits, burdens, or barriers of at home care.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date March 2011
Est. primary completion date May 2007
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 120 Years
Eligibility DISEASE CHARACTERISTICS:

- History of breast cancer

- Lymphedema in one or both arms that occurred during or after breast cancer treatment

- Must have received prior lymphedema treatment by a healthcare professional

- Patients with self-reported arm swelling subsequent to breast cancer treatment that has not been treated by a healthcare professional are not eligible

- Hormone receptor status not specified

PATIENT CHARACTERISTICS:

- Menopausal status not specified

- English speaking

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

Study Design


Related Conditions & MeSH terms


Intervention

Other:
questionnaire administration
Completed self-report form
survey administration
Completed self-report form-other
Procedure:
quality-of-life assessment
Completed self-report form qol

Locations

Country Name City State
United States Vanderbilt-Ingram Cancer Center Nashville Tennessee
United States Vanderbilt-Ingram Cancer Center - Cool Springs Nashville Tennessee
United States Vanderbilt-Ingram Cancer Center at Franklin Nashville Tennessee

Sponsors (2)

Lead Sponsor Collaborator
Vanderbilt University National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Identification and description of barriers to completing recommended at home self-care of lymphedema one time only for approximately 15 minutes
Primary Identification of patients recalled instructions as to at home self-care practices for lymphedema as told to them by healthcare professionals and others one time only for approximately 15 minutes
Primary Identification of current at home self-care practices for lymphedema one time only for approximately 15 minutes
Secondary Relationship between at home self-care activities, symptoms, and quality of life in breast cancer survivors with lymphedema one time only for approximately 15 minutes
Secondary Identification of patient-perceived benefits to at home self-care one time only for approximately 15 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2